Why Is Axsome Therapeutics (AXSM) Stock Up 32% Today?

Axsome Therapeutics (AXSM) stock is soaring higher on Monday after releasing positive results from a Phase 3 clinical trial.

Related Keywords

Jeffrey Cummings ,Drug Administration ,Axsome Therapeutics ,Investors Are Celebrating ,Vinco Ventures ,Monday Stock Market ,